Hero_BottleCloseUp

News & Events

Latest news and events from DOCE

DOCE Researcher Christiane Hampe, PhD, Receives T1D Exchange Biobank Pilot Award

Dr. Christiane Hampe has received a one year pilot research award through the T1D Exchange Biobank Operations Center at the Benaroya Research Institute (BRI)

DOCE Researcher Christiane Hampe, PhD, Receives National Ataxia Foundation Award

Dr. Christiane Hampe has received an award from the National Ataxia Foundation for her project entitled Glutamate Decarboxylase in Cerebellar Ataxia.

DOCE Director Michael Schwartz, MD, Cross-published in Endocrine Society Journals

Dr. Michael Schwartz is author of a recent editorial entitled Can the History of Modern Endocrinology Shape the Future of Obesity?

The Diabetes Research Center (DRC) is soliciting applications for the Pilot and Feasibility, McAbee Fellowship and Stroum Graduate Fellowship Awards.

Letters of Intent are due by January 5, 2015 and the deadline for applications is February 23, 2015.

DOCE Director Michael Schwartz, MD, recognized in European Journal of Clinical Investigation

Dr. Michael Schwartz has been listed as one of the most highly influential biomedical researchers in the paper entitled “A list of highly influential biomedical researchers, 1996-2011″

DOCE researcher Christiane Hampe, PhD, published in Diabetic Medicine

Dr. Christiane Hampe is co-author on the article “Antibodies to islet cell autoantigens, rotaviruses and/or enteroviruses in cord blood and healthy mothers in relation to the 2010–2011 winter viral seasons in Israel: a pilot study” published in Diabetic Medicine.

DOCE Director Michael Schwartz, MD, Featured in ASCI Interview

Dr. Michael Schwartz is featured in an interview by the American Society for Clinical Investigation (ASCI), published on September 10, 2014.

DOCE Researcher Joshua Thaler, MD, PhD, Receives ADA Pathway Award

Dr. Joshua Thaler is one of 5 recipients awarded a Pathway to Stop Diabetes Accelerator Award from the American Diabetes Association. This 5-year, $1.625 million grant entitled ” Modulating glial-neuronal interactions to treat obesity and diabetes” explores the possibility that glial cells (the brain’s damage response cells) in the hypothalamus area of the brain play an important part in the process of becoming obese and developing diabetes.